Live Breaking News & Updates on Curepsp Inc

Stay updated with breaking news from Curepsp inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CurePSP Elects Longtime Board and Community Member as Its Board Chair

CurePSP, the leading research and advocacy nonprofit organization for PSP, CBD and MSA, has elected F. Jackson (Jack) Phillips as the next Chair of the nonprofit's Board of Directors. Phillips will work closely with CurePSP's executive director and chief science officer, Kristophe Diaz, PhD, and the Board, to advance CurePSP's mission and strategic objectives. ....

United-states , Athens , Attikír , Greece , Belgium , Brussels , Bruxelles-capitale , Kristophe-diaz , George-washington-university-business , Curepsp-inc , Wind-energy-corporation , Centers-of-care

Frontotemporal Dementia Management Market Growth Estimated at 6% CAGR Through 2033, FMI Study Report

Frontotemporal Dementia Management MarketThe global Frontotemporal Dementia Management Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Frontotemporal. ....

Amsterdam , Noord-holland , Netherlands , United-states , New-york , Delaware , America , Philip-scheltens , Asia-pacific , Eli-lilly , Bluefield-project-organization , Pfizer-inc

CurePSP Awards Latest Pathway and Pipeline Grants and Urso Student Fellowship Grants Looking to Take Advantage of Recent Neuroscience Breakthroughs

/PRNewswire/ CurePSP has awarded its latest Pathway and Pipeline Grants and Urso Student Fellowships, totaling over $422,000. Recipients of the grants are:. ....

Buenos-aires , Distrito-federal , Argentina , Toronto , Ontario , Canada , Milan , Lombardia , Italy , United-states , Prnewswire-cure , Stewart-clark

Frontotemporal Disorders Treatment Market | Pfizer Inc., Johnson & Johnson, Sanofi S.A., Eli Lilly a

The global Frontotemporal Disorders Treatment Market is anticipated to reach US$ 451.4 million by the end of 2028, according to the company’s most recent research. The frontotemporal disorders therapy market has a sizable growth potential, with an average annual growth rate of 4.7% through 2028, according to the ana. ....

Japan , United-states , Delaware , New-york , America , Eli-lilly , Merck-company-inc , Market-insights-inc , Astrazeneca , Association-for-frontotemporal-degeneration , Glaxosmithkline-plc , Greater-new-york-chamber

CurePSP Strengthens Team with Director of Development and Associate Director of Scientific Affairs and Partnerships

/PRNewswire/ CurePSP, a leading not-for-profit organization dedicated to advancing patient support and treatments of rare neurodegenerative diseases, is. ....

United-states , Spain , Chicago , Illinois , Illinois-wesleyan-university , American , Jennifer-brummet , Prnewswire-cure , Lawrencei-golbe , Kristophe-diaz , American-epilepsy-society , Curepsp-inc